Expert Think Tank: Resources to Improve the Care of Patients With NSCLC and EGFR Mutations

Download All
Gain expert insights on challenges in and best practices for managing EGFR mutation–positive NSCLC with this comprehensive educational program, including expert-authored commentaries and text modules, an on-demand webcast of a CCO live webinar along with an FAQ audio podcast, a regularly updated downloadable teaching slideset, and downloadable clinical resource PDFs.
Edward B. Garon, MD, MS
Program Director
Xiuning Le, MD, PhD
Zofia Piotrowska, MD, MHS
person default
Catherine A. Shu, MD
Mark A. Socinski, MD
Helena A. Yu, MD

Modules

In this module, 5 lung cancer experts review oncology healthcare professional survey results on key educational needs for the multidisciplinary oncology team caring for patients with EGFR-mutated NSCLC, including discussion of standard-of-care practices, the latest clinical data, and ongoing challenges.

Edward B. Garon, MD, MS
Program Director
Xiuning Le, MD, PhD Zofia Piotrowska, MD, MHS Mark A. Socinski, MD Helena A. Yu, MD
Physicians: maximum of 1.25 AMA PRA Category 1 Credits Registered Nurses: 1.25 Nursing contact hours Pharmacists: 1.25 contact hours (0.125 CEUs) Released: September 30, 2022 Expired: September 29, 2023

Downloadable slides capturing key data on standard-of-care practices and ongoing challenges for the multidisciplinary oncology team caring for patients with EGFR-mutated NSCLC as identified by 5 lung cancer experts.

Edward B. Garon, MD, MS
Program Director
Xiuning Le, MD, PhD Zofia Piotrowska, MD, MHS Mark A. Socinski, MD Helena A. Yu, MD
Released: September 30, 2022

Review an expert’s perspective on novel combination therapies and antibody–drug conjugates for the treatment of patients with EGFR-mutated advanced NSCLC in the first-line setting and beyond, including emerging data and key ongoing trials.

person default Catherine A. Shu, MD Physicians: maximum of 0.75 AMA PRA Category 1 Credits Registered Nurses: 0.75 Nursing contact hours Pharmacists: 0.75 contact hours (0.075 CEUs) Released: September 30, 2022 Expired: September 29, 2023

Download these slides for emerging data and a summary of key ongoing clinical trials evaluating novel combination therapies and antibody–drug conjugates for patients with EGFR-mutated advanced NSCLC in the first-line setting and beyond.

person default Catherine A. Shu, MD Released: September 30, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings